6086.HK
FANGZHOU JIANKE
HK$0.91
+3.41%
2026-05-29
About FANGZHOU JIANKE
Fangzhou Inc. provides online chronic disease management services in China. It operates through four segments: Online Retail Pharmacy Services; Comprehensive Medical Services; Wholesale; and Customized Content and Marketing Solutions. The company offers services through online chronic disease management platform to address the needs of patients with chronic disease, such as hypertension, cardiovascular and respiratory diseases. It also engages in the sales of pharmaceutical and healthcare products through online retail pharmacy service platform, third-party platforms, and offline retail pharmacies; and online consultation, e-prescription, physician consultation, physical examination, and surgery service, as well as wholesale of pharmaceutical products. Fangzhou Inc. was founded in 2015 and is based in Guangzhou, China.
Key Fundamentals
P/E Ratio
91.00
Forward P/E
10.22
EPS (TTM)
HK$0.01
ROE
8.3%
Revenue Growth (YoY)
46.8%
Profit Margin
0.3%
Debt/Equity
23.28
Price/Book
6.85
Market Cap
HK$1.26B
Avg Volume (10D)
738K
Recent Breakout Signals
No recent breakout signals detected for 6086.HK.
Recent Price Range (60 Days)
60D High
HK$2.40
60D Low
HK$0.82
Avg Volume
3.6M
Latest Close
HK$0.91
Get breakout alerts for 6086.HK
Sign up for Breakout Scanner to receive daily notifications when 6086.HK triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
FANGZHOU JIANKE (6086.HK) is listed on the Hong Kong Exchanges (HKEX). Breakout Scanner monitors 6086.HK daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. 6086.HK operates in the Healthcare sector within the Pharmaceutical Retailers industry. Data is provided for informational purposes only and does not constitute financial advice.